— Know what they know.
Not Investment Advice
Also trades as: 2616.HK (HKSE) · $vol 8M

CSPHF OTC

CStone Pharmaceuticals
1W: +4.9% 1M: +10.4% 3M: +26.9% YTD: -15.4% 1Y: -24.5% 3Y: +51.0% 5Y: -32.0%
$0.76
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $1.2B mcap · 1.24B float · 0.0003% daily turnover · Short 71% of daily vol

📊 Key Metrics

TTM
$597M
Revenue
-36.4% YoY
$-655M
Net Income
+26.6% YoY
$-520M
Free Cash Flow
+44.8% YoY
44.7%
Gross Margin
-115.0%
Op. Margin
-123.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-74.4%
ROA-36.5%
ROIC-553.0%

Valuation

P/E-17.9
P/B5.7
EV/EBITDA0.0

Leverage

Debt/Equity0.28
Current Ratio3.58
Interest Cov.-38.8x

Quality Scores

Piotroski F4/9
Altman Z—
Beneish M-3.05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms